<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38317942</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Long-term rheumatoid manifestations as a consequence of COVID-19 and/or vaccination: A case report after a 2-year follow-up.</ArticleTitle><Pagination><StartPage>e24982</StartPage><MedlinePgn>e24982</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e24982</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2024.e24982</ELocationID><Abstract><AbstractText>COVID-19 is now established as a multi-organ involvement disease with a broad range of manifestations. Identification of post-acute COVID-19 incidence is critical according to increasing number of late symptoms reports. Hereby, we report a case with a past history of COVID-19 who presented different manifestations including osteoarticular and neurological involvement within a long-term follow-up. The organs involvement initiated lately after primary vaccinations (with inactivated vaccine) and lasted few months without any pre-existing medical condition. However, upon the completion of the vaccine schedule and receiving a protein subunit vaccine, PastoCovac Plus, as a booster, the symptoms improved substantially and resolved, though in the reinfection episode partial, reoccurrence was recorded. This presentation can be a challenging issue owing to the fact that the majority of global population are vaccinated and also experience COVID-19 in this era and sometimes differentiation between consequences of the virus as post COVID-19 or the vaccination side effects is difficult.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadat Larijani</LastName><ForeName>Mona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banifazl</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iranian Society for Support of Patients with Infectious Disease, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karami</LastName><ForeName>Afsaneh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramezani</LastName><ForeName>Amitis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">Late adverse events</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Vaccine</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>6</Day><Hour>3</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38317942</ArticleId><ArticleId IdType="pmc">PMC10840001</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2024.e24982</ArticleId><ArticleId IdType="pii">S2405-8440(24)01013-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sadat Larijani M., et al. Characterization of long COVID-19 manifestations and its associated factors: a prospective cohort study from Iran. Microb. Pathog. 2022;169</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9176176</ArticleId><ArticleId IdType="pubmed">35690233</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadat Larijani M., et al. Pathogens and Disease; 2023. Assessment of Long-Term Adverse Events Regarding Different COVID-19 Vaccine Regimens within an 18-month Follow-Up Study; p. ftad010.</Citation><ArticleIdList><ArticleId IdType="pubmed">37230943</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento T.C.D.C., et al. Vaccination status and long COVID symptoms in patients discharged from hospital. Sci. Rep. 2023;13(1):2481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9922040</ArticleId><ArticleId IdType="pubmed">36774419</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wu H., Xia S.L. New-onset arthritis following COVID-19 vaccination: a systematic review of case reports. Vaccines. 2023;11(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10055862</ArticleId><ArticleId IdType="pubmed">36992249</ArticleId></ArticleIdList></Reference><Reference><Citation>Golstein M.A., Fagnart O., Steinfeld S.D. Reactive arthritis after COVID-19 vaccination: 17 cases. Rheumatology. 2023:kead169.</Citation><ArticleIdList><ArticleId IdType="pubmed">37084272</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadat Larijani, M., et al., A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports, in Preprints2023, Preprints..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10676592</ArticleId><ArticleId IdType="pubmed">38008729</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebowitz E., Kim J.S., Magro C. Reactive arthritis following COVID-19 vaccination with BNT162b2. JAAD Case Reports. 2022;24:108&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9090820</ArticleId><ArticleId IdType="pubmed">35571454</ArticleId></ArticleIdList></Reference><Reference><Citation>Terracina K.A., Tan F.K. Flare of rheumatoid arthritis after COVID-19 vaccination. Lancet Rheumatol. 2021;3(7):e469&#x2013;e470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009616</ArticleId><ArticleId IdType="pubmed">33817664</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., et al. Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine. 2023;41(11):1783&#x2013;1790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Hamdh B., Nazzal Z. A prospective cohort study assessing the relationship between long-COVID symptom incidence in COVID-19 patients and COVID-19 vaccination. Sci. Rep. 2023;13(1):4896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10039348</ArticleId><ArticleId IdType="pubmed">36966161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramezani A., et al. PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals. Sci. Rep. 2023;13(1):8065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10195798</ArticleId><ArticleId IdType="pubmed">37202438</ArticleId></ArticleIdList></Reference><Reference><Citation>COVAXIN&#xae; (BBV152) &#x2013; Inactivated, COVID-19 Vaccine, World Health Organization.</Citation></Reference><Reference><Citation>Farahmand B., et al. Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine. Heliyon. 2023;9(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10551543</ArticleId><ArticleId IdType="pubmed">37810803</ArticleId></ArticleIdList></Reference><Reference><Citation>Jali I. Reactive arthritis after COVID-19 infection. Cureus. 2020;12(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779130</ArticleId><ArticleId IdType="pubmed">33409010</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;nge B.L., Hermansen M.-L.F., Storgaard M. Reactive arthritis after COVID-19. BMJ Case Rep. 2021;14(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929821</ArticleId><ArticleId IdType="pubmed">33653867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparotto M., et al. Post-COVID-19 arthritis: a case report and literature review. Clin. Rheumatol. 2021;40(8):3357&#x2013;3362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7882861</ArticleId><ArticleId IdType="pubmed">33587197</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B., et al. Long-COVID and post-COVID Health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Mung S.M., et al. Inflammatory arthritis associated with COVID-19 vaccination. Cureus. 2023;15(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10082647</ArticleId><ArticleId IdType="pubmed">37038568</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T., et al. Case report: new-onset rheumatoid arthritis following COVID-19 vaccination. Front. Immunol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198350</ArticleId><ArticleId IdType="pubmed">35720324</ArticleId></ArticleIdList></Reference><Reference><Citation>Teijaro J.R., Farber D.L. COVID-19 vaccines: modes of immune activation and future challenges. Nat. Rev. Immunol. 2021;21(4):195&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934118</ArticleId><ArticleId IdType="pubmed">33674759</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin U., Karik&#xf3; K., T&#xfc;reci &#xd6;. mRNA-based therapeutics--developing a new class of drugs. Nat. Rev. Drug Discov. 2014;13(10):759&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pubmed">25233993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>